CIBC analyst Mark Jarvi reiterated an Outperformer rating and $37.00 price target on Solventum (NYSE: SOLV)

The analyst commented, "We remain constructive on SOLV given a supportive end-market backdrop and the company’s strong competitive position, which should continue to translate into strong backlog generation and improving services attach rates. In our view 2026 guidance (slightly above consensus estimates) has some conservatism (particularly on gross margins), with potential upside assuming SOLV’s strong execution continues, it can benefit from ongoing repair work, and management deploys incremental balance sheet capacity towards M&A (sounds like deals could come in 2026) to expand its scale, footprint and service offerings. We maintain our Outperformer rating."

For an analyst ratings summary and ratings history on Solventum click here. For more ratings news on Solventum click here.

Shares of Solventum closed at $67.14 yesterday.